M&A Deal Summary |
|
|---|---|
| Date | 2009-02-26 |
| Target | COR pumps + compressors AG |
| Sector | Machinery |
| Buyer(s) | Robert Bosch |
| Sellers(s) | Triginta Capital |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1886 |
| Sector | Diversified |
| Employees | 300,000 |
| Revenue | 52.0B EUR (2012) |
Robert Bosch GmbH is a diversified technology, electronics, and automotive manufacturing company. The Company is privately owned and was established in 1886.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 22 |
| Sector: Machinery M&A | 3 of 4 |
| Type: Add-on Acquisition M&A Deals | 9 of 18 |
| Country: Germany M&A | 2 of 6 |
| Year: 2009 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-12-18 |
Blaupunkt
Schonefeld, Germany Blaupunkt stands for a broad range of high-quality products from the field of consumer electronics. Blaupunkt was founded in 1924 and is based in Schonefeld, Germany. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-04-01 |
Visual Telecommunications Network
McLean, Virginia, United States ViTel Net is a provider of remote patient monitoring. ViTel Net develops and sells technologies that allow clinicians to remotely manage patient health regardless of geographic boundaries. The company’s products are designed for home health monitoring of patients with chronic conditions. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2000 |
| Size | Middle-Market |
| Type | Sector Agnostic |
Triginta Capital is a private equity firm focused on making control investments in small and medium-sized companies in German speaking Europe. Triginta generally seeks businesses valued up to €20 million in the manufacturing and services sectors (B2B and B2C). In addition to investing in companies, Triginta also acquires entire portfolios of investments. Triginta Capital was formed in 2000 and is based in Dusseldorf.
| DEAL STATS | # |
|---|---|
| Overall | 13 of 26 |
| Sector: Machinery M&A | 1 of 2 |
| Type: Add-on Acquisition M&A Deals | 4 of 9 |
| Country: Germany M&A | 9 of 21 |
| Year: 2009 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-09-03 |
Neurotech Pharmaceuticals
Lincoln, Rhode Island, United States Developer of protein-drug delivery systems for the treatment of ophthalmologic diseases such as retinal degeneration (age-related macular degeneration, retinitis pigmentosa) and vascular eye diseases (diabetic retinopathy). |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-08-07 |
Atto-Tec
Siegen, Germany Atto-Tec develops and produces fluorescent dyes for medical diagnostics and biochemistry. Its dyes are used for fluorescence microscopy imaging, offering a highly differentiated panel. Their brightness and photostability make them the reagents of choice for demanding applications. Atto-Tec was formed in 1999 and is based in Siegen, Germany. |
Sell | - |
